Colinz

Date:

zSltOlZ0LG

To,

Limited
BombaY Stocl< Exchange
Phiroze "teeieeboY Towers'
Dalal Street,
l!1un-ri,'ai - 400001

Dear 5ir,

of the Board Me
lUb-S--Ulqome
r*98-!q-de!-13-1219

TheMeetingofBoardofDirectorSwaSheldonFriday,28thoct,2016at12'30P.M.
Financial
attheregisteredofficeoftheco,p*vu,o-,o,,Pratil<lndustrialEstate,Mulund
has approved the Un- audited
orroi,
Mumbai
noal,
Lint
Goregaon
on 30th Sep' 2016'
Resulls for the quarter ended
and record'
lhis is t'ci your information
Thanl<ing You,
You rs f aithf ullY,

P*th
fulANAG?iT6 DIRECTOR

DIN: i)CI8?5886

Cotinz Laboratories Limited

cIN NO- L24200MH1986PLC041
.r1-.,r^^^:r^r

rrrrrrrrnrl I

128

ink Raad P Box No. 17339 Mumbai - 400 078' INDIA

Colinz
COLINZ LABORATORIES LIMITED
CIN NO : L24200MH1986PLC041128
078'
A-101, Pratik lnd. Estate, Next to Fortis Hospital, Mulund'Goregaon Link Road, Mumbai - 400
"
''
SEPTEMBER,2O16
3OTH
ENDED
UN.AUDITED RESULTS FOR THE QUARTER

(Rupees in " 0(

,t:::::r
S. No.

{)uartcr entled

Particulars
30-Sep-1

20,8381

1,$71
22,440,'

1,3161

19.5221

Total lncome trortr OPeration

Expenditure

19,5221

20,2g1

44,715:i

45,0911

6471

2,7$l

1,333t

83,989
3,036

$,7581

80,953

rc,644i.

in trade

'l

_l

1e 6441

41,9621

43 TsBl

2,9771

3,3461

9,7251

7,5261

17,528

2,9101

2 6601

4,5341

6 1e2l

(1,854)l
7,4441

n,ual

(10e)l

5,5701
2,4601

13,345
3,962

7 3761

7,5361

663

4 006l
21 se6l

ls,td+l
37sl

4441

705

20s
I

14,820

r
|

I
I

1.4041

3,3001

7,240
41,140

o,zezl

2,818
12,985

42,7301
I o28l

79,261
1,692

1e 3oel
302

910

4641

98C

1,4e2',
5e8l

2,672

rn1

1,514

894

1,51t

llnterest

2531

2711

260l

lProfit /Loss after lnterest but before exceptional items (5-6)

830

3781

377

1,208

lExceotional iterls

637

I
I

1,158

-l

Profit /Loss before Tax (7-8)

lTax Exp"nses (Provrsion for Taxationr Current tax
oeffered tax
I

10

28,623

1,3251

822

6491

1,0831

o.oool
a,ezol

7o2l

1,732
524

80,953
I

6,748I

Olher ExpenortLlre

41,s621
---t--

22,440]l

662
3.2341

23,8??l

Net Sales
(b) Other Operatittg Income

(f)

I
I

Total Expenciiiure
Profit /Loss frorn Operation Before Other lncome (1-2)
lOther inconre,lLoss)
items (3+4)
lProfit /Loss before lrrterest & Exceptional

I
I

(a) Consumption of Materials

(b) Purchase of Goods Traded
(c) (lncrease)/Decrease in stock
(d) Staff Cost
(e) Depreciation

tt

(a) lncorrre frorn Operation

Gross Sales
Less. Exctsr: DLIIY

31-Mar-16

30-Sep-161 30-SeP-151

30-Sep-1 {

30-Jun-1(

PART -t
4

AuOrteO
-audited
Half Year Ended l\i ear Ended

Lln
---_-.-.--l-

]n -arrdited

83;

3ttJ

(601

(601

3771

1,2A;

(75)l
(e5)

(1

20)

(1

t)-7

55)

(145)

I
I

11

irter Tax (9-10)

lNet ProfitiLoss
I

12
13
14

Equity Snare Capital (Face Value 101 Per Share)

l[Net of altotment n]orley in arrearsl
lRur"ru., Excluding Revaluation Reserves
per share (EPS) before extraordinary item (not Annualised)
lSarning
Basrc & Dilr,led
I

lnaiO

770

J to

207

1,088

594

35,441

35,441

354 39

35,441

354,39

L,p

35,44
8,41

0.2

it

l,,l

D,r*Led

PART -II PARTICULARS OFSIIAREHOLDING

Public Sharehoiciing
1
i) Nunrrrer oi ijhares
il) Percentage oi shareholdit-lg
Prornoters and prornoter group Shareholding
Z

2,894,9011
63.33%

2,894,901
63 33%

2 894 901 2,894,901

63.33%
63.33%l
|

':T#;l

2,894,901
63.33%

a) Pledgecl/Etrcumbered

:t

l) Number of shares
ll)PercenlaEe of sheres (as a % ol the total shareholding of promoter
and pronroter gro!p)
lll)Perceniage of sirares (as a% of the total share capital of tlle company)

bl Non-encurlbereil
lil Number of Sharas
I

ri)Percentage of si,at e> I as

1,676,099

a'l

of the tolal shareholding of promoter and

36.67%

1,676,099

1,676,099

1,676,099

l7o

36.67%

36.67%

00%

100%

100%

JO.O

1,676,099 1,676,099
36.67%
36.67%

lpromoter group )
of shat es i as a % of the total share capital of the company)
I Li )Percenlaqe

00%

3 MONTHS ENOED 30.9-2016

INVESTORS COMPLAINTS
Perrding at Begtnign of lnc Quarter

NiI

Nil

Recei',,ed DLtring tite Quarier

Nit

2*\*

Diposed of Durrtrg the Qr,rarter

Renraining irr the errd ci lhe

Quarter

100%

100%

COfinz I abOfal sriec, I it nilad

cIN NO-

\{/#

L24200MH1986PLC041 128
hIr

'S

Golinz
EQUIITY AND LIABILITY
Shareholders Funds
Share Capltat
Reserve and Surplus
Tatai

a)
b)

,\.-O\

ll)
b)
!')

35,441

35,441

27,140
62,s81

CtiRlil,.\ I LL\UIl.It'tIrS

l-ong lo nl ltolrori ing

l)cllcrcd tar liabilir,r( rrct)

f)tll!r l()rrt er'l, li;rl,ilitr

't6,159

15,962

4,492

4,492
68

20,724

CURRENT LIABILITIES
Short term borrowing
Trade payable

20,522

5,69;

Other current liabilities

Short term provision

8,621

Total

12,371

14,319

Total ( 1+2+3
ASSETS
NON CURRENT ASSETS
Fixed Assets
Non current investments
Long terms loan and advance
Other Non current assets
-f

28,810
2,859
12,993

otal

44,662

CURRENT ASSETS
lnventories
Trade receivable

'19,897

22,185

Cash and cash equivalents

Short term loan and advances

18,461

16,165

55,499

52,760

13,467
943

Total
Total ( 1+2

1. The above financial resuits have been taken on record at a meeting of Board
of Directors held

on 28-|0-2016

The Company operates in single segment of manufacture of pharmaceutical formulations

Hence Accounting Standard on segment reporting

is not applicable.

3) Previous period figures have been regrouped wherever required.

For and on
M/S. COLINZ

. L. S. MANI

Col i nz Laboratories Lim ited

crN No- L24200MH1986PLC041 128
GOfp.Off.:A/l0l.PfatikEstate.NerttoForlisFlasnital

Mrrlrrnr{lintzr)aar{ D Elavrrr^ r?a.nrr..-L^i

,nnn,a rr,^r^